Outcomes and atrial substrate analysis in patients with HIV undergoing atrial fibrillation ablation.
Austin ChengJessica QiuChirag BarbhaiyaLeonid GarberDouglas HolmesLior JankelsonAlexander KushnirRobert KnottsScott BernsteinDavid ParkMichael SpinelliLarry A ChinitzAnthony AizerPublished in: Journal of cardiovascular electrophysiology (2022)
Ablation to treat atrial fibrillation in patients with HIV, but without overt AIDS is frequently successful therapy. The majority of patients with recurrence of atrial fibrillation had pulmonary vein reconnection, suggesting infrequent nonpulmonary vein substrate. In this population, the left atrial voltage in patients with HIV is similar to that of patients without HIV. These findings suggest that the pulmonary veins remain a critical component to the initiation and maintenance of atrial fibrillation in patients with HIV.
Keyphrases
- atrial fibrillation
- left atrial
- antiretroviral therapy
- catheter ablation
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hiv aids
- men who have sex with men
- hepatitis c virus
- oral anticoagulants
- left atrial appendage
- mitral valve
- direct oral anticoagulants
- heart failure
- left ventricular
- end stage renal disease
- south africa
- type diabetes
- peritoneal dialysis
- percutaneous coronary intervention
- pulmonary hypertension
- prognostic factors
- chronic kidney disease
- bone marrow
- coronary artery disease
- newly diagnosed
- pulmonary embolism
- insulin resistance
- metabolic syndrome
- skeletal muscle
- amino acid
- smoking cessation
- patient reported outcomes